TrialInternational journal of colorectal disease2012

A double-blind placebo-controlled trial to study therapeutic effects of probiotic Escherichia coli Nissle 1917 in subgroups of patients with irritable bowel syndrome.

Wolfgang Kruis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.